4.3 Article

Dietary intake and risk of non-severe hypoglycemia in adolescents with type 1 diabetes

期刊

JOURNAL OF DIABETES AND ITS COMPLICATIONS
卷 31, 期 8, 页码 1340-1347

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jdiacomp.2017.04.017

关键词

Type 1 diabetes; Dietary intake; Nutrition; Hypoglycemia; Continuous glucose monitoring

资金

  1. NIH/NIDDK [1UC4DK101132]
  2. Helmsley Charitable Trust

向作者/读者索取更多资源

Aims: To determine the association between dietary intake and risk of non-severe hypoglycemia in adolescents with type 1 diabetes. Methods: Type 1 adolescents from a randomized trial wore a blinded continuous glucose monitoring (CGM) system at baseline for one week in free-living conditions. Dietary intake was calculated as the average from two 24-h dietary recalls. Non-severe hypoglycemia was defined as having blood glucose <70 mg/dL for >= 10 min but not requiring external assistance, categorized as daytime and nocturnal (11 PM-7AM). Data were analyzed using logistic regression models. Results: Among 98 participants with 14,277 h of CGM data, 70 had daytime hypoglycemia, 66 had nocturnal hypoglycemia, 55 had both, and 17 had neither. Soluble fiber and protein intake were positively associated with both daytime and nocturnal hypoglycemia. Glycemic index, monounsaturated fat, and polyunsaturated fat were negatively associated with daytime hypoglycemia only. Adjusting for total daily insulin dose per kilogram eliminated all associations. Conclusions: Dietary intake was differentially associated with daytime and nocturnal hypoglycemia. Over 80% of type 1 adolescents had hypoglycemia in a week, which may be attributed to the mismatch between optimal insulin dose needed for each meal and actually delivered insulin dose without considering quality of carbohydrate and nutrients beyond carbohydrate. (C) 2017 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Outcomes in Pump- and CGM-Baseline Use Subgroups in the International Diabetes Closed-Loop Trial

Laya Ekhlaspour, Dan Raghinaru, Gregory P. Forlenza, Elvira Isganaitis, Yogish C. Kudva, David W. Lam, Camilla Levister, Grenye O'Malley, Mei Mei Church, John W. Lum, Bruce Buckingham, Sue A. Brown

Summary: The study investigated the potential benefits of automated insulin delivery among individuals with type 1 diabetes, regardless of their baseline device use or CGM status. The results showed that the closed-loop control system significantly improved glycemic outcomes in both insulin pump and MDI users with or without CGM.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2023)

Review Endocrinology & Metabolism

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

Moshe Phillip, Revital Nimri, Richard M. Bergenstal, Katharine Barnard-Kelly, Thomas Danne, Roman Hovorka, Boris P. Kovatchev, Laurel H. Messer, Christopher G. Parkin, Louise Ambler-Osborn, Stephanie A. Amiel, Lia Bally, Roy W. Beck, Sarah Biester, Torben Biester, Julia E. Blanchette, Emanuele Bosi, Charlotte K. Boughton, Marc D. Breton, Sue A. Brown, Bruce A. Buckingham, Albert Cai, Anders L. Carlson, Jessica R. Castle, Pratik Choudhary, Kelly L. Close, Claudio Cobelli, Amy B. Criego, Elizabeth Davis, Carine de Beaufort, Martin de Bock, Daniel J. DeSalvo, J. Hans DeVries, Klemen Dovc, Francis J. Doyle, Laya Ekhlaspour, Naama Fisch Shvalb, Gregory P. Forlenza, Geraldine Gallen, Satish K. Garg, Dana C. Gershenoff, Linda A. Gonder-Frederick, Ahmad Haidar, Sara Hartnell, Lutz Heinemann, Simon Heller, Irl B. Hirsch, Korey K. Hood, Diana Isaacs, David C. Klonoff, Olga Kordonouri, Aaron Kowalski, Lori Laffel, Julia Lawton, Rayhan A. Lal, Lalantha Leelarathna, David M. Maahs, Helen R. Murphy, Kirsten Norgaard, David O'Neal, Sean Oser, Tamara Oser, Eric Renard, Michael C. Riddell, David Rodbard, Steven J. Russell, Desmond A. Schatz, Viral N. Shah, Jennifer L. Sherr, Gregg D. Simonson, R. Paul Wadwa, Candice Ward, Stuart A. Weinzimer, Emma G. Wilmot, Tadej Battelino

Summary: The global prevalence of diabetes continues to be a challenge and the advances in automated insulin delivery (AID) technologies have shown to be safe and effective in helping patients achieve their glycemic goals. However, there is a lack of guidance for clinicians on using AID systems in clinical settings.

ENDOCRINE REVIEWS (2023)

Article Endocrinology & Metabolism

Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients

Soohee Cho, Tim Vigers, Laura Pyle, Anna Franklin, Jenna Sopfe, Frankie Jeney, Gregory Forlenza

Summary: Malglycemia in pediatric, adolescent, and young adult patients undergoing hematopoietic stem cell transplant is associated with increased infection and mortality rate. Most patients in this study had suboptimal glycemic control in the peri-HSCT period. Further research is needed to develop screening and treatment strategies to improve glycemic control and clinical outcomes.

DIABETES TECHNOLOGY & THERAPEUTICS (2023)

Article Oncology

Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute Lymphoblastic Leukemia and Lymphoma

Jenna Demedis, Sharon Scarbro, Krithika Suresh, Kelly Maloney, Gregory P. Forlenza

Summary: Transient hyperglycemia during induction chemotherapy in patients with acute lymphoblastic leukemia (ALL) is associated with increased morbidity and mortality. Glucocorticoids, asparaginase, and stress are proposed causal factors. This study aimed to characterize glycemic control throughout ALL therapy and evaluate risk factors and outcomes associated with increased mean glucose and glucose variability during induction chemotherapy. Retrospective review of pediatric/young adult patients treated for ALL from 2010 to 2014 identified high mean glucose levels during induction, pretreatment, delayed intensification, and maintenance cycles. Factors such as Down syndrome, age, and overweight/obesity were associated with higher mean glucose or glucose variability during induction. However, these glycemic measures were not associated with increased risk of infection, relapse, or death.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Associations of disordered eating with the intestinal microbiota and short-chain fatty acids among young adults with type 1 diabetes

Daria Igudesman, Jamie Crandell, Karen D. Corbin, Dessi P. Zaharieva, Ananta Addala, Joan M. Thomas, Cynthia M. Bulik, Brian W. Pence, Richard E. Pratley, Michael R. Kosorok, David M. Maahs, Ian M. Carroll, Elizabeth J. Mayer-Davis

Summary: This study aimed to evaluate the association between disordered eating and gut microbiota-derived short chain fatty acids (SCFA) in individuals with type 1 diabetes. The results showed that disordered eating and insulin restriction were associated with a reduced abundance of gut microbes that produce SCFA.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2023)

Review Endocrinology & Metabolism

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

Tadej Battelino, Charles M. Alexander, Stephanie A. Amiel, Guillermo Arreaza-Rubin, Roy W. Beck, Richard M. Bergenstal, Bruce A. Buckingham, James Carroll, Antonio Ceriello, Elaine Chow, Pratik Choudhary, Kelly Close, Thomas Danne, Sanjoy Dutta, Robert Gabbay, Satish Garg, Julie Heverly, Irl B. Hirsch, Tina Kader, Julia Kenney, Boris Kovatchev, Lori Laffel, David Maahs, Chantal Mathieu, Didac Mauricio, Revital Nimri, Rimei Nishimura, Mauro Scharf, Stefano Del Prato, Eric Renard, Julio Rosenstock, Banshi Saboo, Kohjiro Ueki, Guillermo E. Umpierrez, Stuart A. Weinzimer, Moshe Phillip

Summary: Randomised controlled trials and other prospective clinical studies have traditionally used HbA1c as a measure of average blood glucose levels, but with the increasing use of continuous glucose monitoring (CGM), CGM-derived metrics are being considered for use in these studies. This consensus statement recommends the use of CGM data in clinical studies to provide additional clinical information beyond HbA1c. Standardizing the collection and reporting of CGM data in clinical trials can enhance the interpretability of the data and inform therapeutic decisions related to hypoglycaemia, postprandial hyperglycaemia, and glucose variability.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Project ECHO Diabetes Cost Modeling to Support the Replication and Expansion of Tele-mentoring Programs in Non-research Settings

Eugene M. Lewit, Lauren E. Figg, Ananta Addala, Stephanie L. Filipp, Rayhan Lal, Matthew J. Gurka, Jill Boylston Herndon, Michael J. Haller, David M. L. Maahs, Ashby F. J. Walker

Summary: Project ECHO Diabetes is a tele-education learning model that aims to improve care for marginalized communities with diabetes. It utilizes expert hub teams and primary care providers to provide additional diabetes support. The costs of operating a Project ECHO Diabetes hub, including personnel and diabetes support coach costs, were estimated.

DIABETES THERAPY (2023)

Article Endocrinology & Metabolism

Adding glycemic and physical activity metrics to a multimodal algorithm-enabled decision- support tool for type 1 diabetes care: Keys to implementation and opportunities

Dessi P. Zaharieva, Ransalu Senanayake, Conner Brown, Brendan Watkins, Glenn Loving, Priya Prahalad, Johannes O. Ferstad, Carlos Guestrin, Emily B. Fox, David M. Maahs, David Scheinker

Summary: Stanford University has utilized algorithm-enabled patient prioritization and remote patient monitoring to improve clinical workflows and glucose control in youth with type 1 diabetes. The care model integrates continuous glucose monitoring data and aims to incorporate exercise data to better manage patients' needs and help healthcare professionals make informed decisions. Regular exercise is crucial for cardiovascular fitness and overall well-being, but can impact blood glucose levels. By integrating physical activity metrics, the model aims to identify whether patients are meeting exercise guidelines and provide clinically relevant information.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Situational Awareness and Proactive Engagement Predict Higher Time in Range in Adolescents and Young Adults Using Hybrid Closed-Loop

Laurel H. Messer, Paul F. Cook, Stephen Voida, Casey Fiesler, Emily Fivekiller, Chinmay Agrawal, Tian Xu, Gregory P. Forlenza, Sriram Sankaranarayanan

Summary: The study aims to assess the situational awareness of adolescents regarding glucose control and their engagement with the Control-IQ system. The results show that situational awareness is an independent predictor of time in range, with proactive engagement predicting better control and reactive engagement predicting lower control.

PEDIATRIC DIABETES (2023)

Article Medicine, General & Internal

Disparities in Hemoglobin A(1c) Levels in the First Year After Diagnosis Among Youths With Type 1 Diabetes Offered Continuous Glucose Monitoring

Ananta Addala, Victoria Ding, Dessi P. Zaharieva, Franziska K. Bishop, Alyce S. Adams, Abby C. King, Ramesh Johari, David Scheinker, Korey K. Hood, Manisha Desai, David M. Maahs, Priya Prahalad

Summary: Continuous glucose monitoring (CGM) is associated with improved HbA(1c) in youths with type 1 diabetes, but minority groups and those with public insurance face more barriers to access. Early initiation of CGM can reduce disparities and improve outcomes.

JAMA NETWORK OPEN (2023)

Review Endocrinology & Metabolism

Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking

Grazia Aleppo, Irl B. Hirsch, Christopher G. Parkin, Janet McGill, Rodolfo Galindo, Davida F. Kruger, Carol J. Levy, Gregory P. Forlenza, Guillermo E. Umpierrez, George Grunberger, Richard M. Bergenstal

Summary: Numerous studies have shown the clinical benefits of continuous glucose monitoring (CGM) in individuals with type 1 and type 2 diabetes who receive intensive insulin treatment. Despite the increasing evidence, insurance coverage for CGM is limited or nonexistent for individuals treated with less-intensive insulin therapy or noninsulin medications.

DIABETES TECHNOLOGY & THERAPEUTICS (2023)

Article Endocrinology & Metabolism

Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers

Korey K. Hood, William H. Polonsky, Sarah A. MacLeish, Carol J. Levy, Gregory P. Forlenza, Amy B. Criego, Bruce A. Buckingham, Bruce W. Bode, David W. Hansen, Jennifer L. Sherr, Sue A. Brown, Daniel J. DeSalvo, Sanjeev N. Mehta, Lori M. Laffel, Anuj Bhargava, Lauren M. Huyett, Todd E. Vienneau, Trang T. Ly

Summary: The study evaluated the impact of a tubeless insulin delivery system on psychosocial outcomes in children and adolescents with type 1 diabetes. The results showed significant improvements in diabetes-related distress, insulin delivery satisfaction, and system usability after using the system. Caregivers of children also experienced improved well-being, confidence in managing hypoglycemia, and sleep quality.

PEDIATRIC DIABETES (2023)

Article Medicine, General & Internal

Recruiting historically under-represented individuals into Project ECHO Diabetes: using barrier analysis to understand disparities in clinical research in the USA

Ananta Addala, Melanie Hechavarria, Lauren Figg, Xanadu Roque, Stephanie L. Filipp, Claudia Anez-Zabala, Rayhan Lal, Matthew J. Gurka, Michael J. Haller, David M. Maahs, Ashby F. Walker

Summary: The study aims to explore the recruitment and retention issues of under-represented populations in diabetes research and provides some solutions. The findings suggest that collaborations with trusted healthcare centers in local communities can effectively improve recruitment and retention rates. In addition, flexible consent processes, adequate funding, and analogue communication methods are also helpful in addressing recruitment and retention barriers.

BMJ OPEN (2023)

Article Endocrinology & Metabolism

The proteome and phosphoproteome of circulating extracellular vesicle-enriched preparations are associated with characteristic clinical features in type 1 diabetes

Anna Casu, Yury O. Nunez O. Lopez, Gongxin Yu, Christopher Clifford, Anika Bilal, Alejandra M. Petrilli, Heather Cornnell, Elvis Alvarez Carnero, Ananya Bhatheja, Karen D. Corbin, Anton Iliuk, David M. Maahs, Richard E. Pratley

Summary: This pilot study aimed to characterize the proteomic and phosphoproteomic landscape of circulating extracellular vesicle (EV)-enriched preparations in individuals with type 1 diabetes (T1D) and healthy controls. The study found differential abundances of proteins and phosphoproteins in participants with T1D compared to controls, including some well-known EV proteins. The analysis also revealed protein modules associated with pancreas size, inflammation, and immune response.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Health Care Sciences & Services

Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States

Joseph E. Biskupiak, Mafalda Ramos, Carol J. Levy, Greg Forlenza, Colin Hopley, Jennifer Boyd, Dan Swift, Mark Lamotte, Diana Brixner

Summary: A tubeless, on-body automated insulin delivery system has shown to improve glycated hemoglobin A1c levels and blood glucose range in both adults and children with type 1 diabetes. Cost-effectiveness analyses suggest that this system is a cost-effective treatment option for type 1 diabetes from a US payer's perspective.

JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2023)

暂无数据